Skip to main content

Peer Review reports

From: Master protocol to assess the long-term safety in kidney transplant recipients who previously received Medeor’s cellular immunotherapy products: the MDR-105-SAE

Original Submission
28 Sep 2022 Submitted Original manuscript
13 Nov 2022 Reviewed Reviewer Report - Jianghua Chen
22 Feb 2023 Author responded Author comments - Sam Kant
Resubmission - Version 2
22 Feb 2023 Submitted Manuscript version 2
27 Feb 2023 Editorially accepted
11 Mar 2023 Article published 10.1186/s13063-023-07204-4

You can find further information about peer review here.

Back to article page